CD117 single positive cells were a minority population of cells across all cell lines tested, in agreement with a previous study of ovarian cancer xenografts showing that CD117+ cells comprised less than two percent of the total tumor cells, and that transplantation assays required 100-fold fewer CD117+ cells relative to CD117- cells [45]. The gene discussed is KIT; the disease is ovarian cancer.